Insider Buying: Option Care Health (NASDAQ:OPCH) CEO Buys 12,500 Shares of Stock

Option Care Health, Inc. (NASDAQ:OPCH) CEO John Charles Rademacher acquired 12,500 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares in the company, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Option Care Health Trading Up 5.5%

Shares of OPCH stock traded up $1.11 on Monday, reaching $21.14. 7,195,534 shares of the stock were exchanged, compared to its average volume of 2,140,592. The stock has a market cap of $3.32 billion, a P/E ratio of 16.39, a price-to-earnings-growth ratio of 1.12 and a beta of 0.68. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The firm has a 50 day moving average of $29.15 and a two-hundred day moving average of $30.74. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, research analysts anticipate that Option Care Health, Inc. will post 1.69 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on OPCH shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a report on Friday. Stephens set a $30.00 price objective on Option Care Health in a report on Friday. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. TD Cowen decreased their price target on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research report on Friday. Finally, UBS Group decreased their price target on shares of Option Care Health from $45.00 to $39.00 and set a “buy” rating for the company in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $32.08.

Hedge Funds Weigh In On Option Care Health

Large investors have recently modified their holdings of the stock. Durable Capital Partners LP raised its stake in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after acquiring an additional 752,058 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in Option Care Health by 6.2% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock worth $135,355,000 after acquiring an additional 247,118 shares during the period. Dimensional Fund Advisors LP raised its stake in Option Care Health by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,840,648 shares of the company’s stock worth $122,367,000 after acquiring an additional 44,252 shares during the period. Finally, Morgan Stanley raised its stake in Option Care Health by 13.3% during the fourth quarter. Morgan Stanley now owns 3,410,233 shares of the company’s stock worth $108,650,000 after acquiring an additional 400,740 shares during the period. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.